Epigenetics Market to 2025 - Global Analysis and Forecasts by Product (Reagents, Kits, Enzymes, Instruments and Consumables, and Bioinformatics Tools); By Technology (Histone Modification, DNA Methylation, and Other Technologies); By Application (Metabolic Diseases, Oncology, Cardiovascular Diseases, Developmental Biology, and Other Applications), & End User (Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies)
Report Code: TIPHE100000971 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Epigenetics is the study of genetic changes in gene without the involvement of changes to the underlying DNA sequence. Epigenetic change is a regular and natural occurrence but can also be influenced by several factors including age, the environment/lifestyle, and disease state.
Deteriorating sequencing costs & time, growing research activities, availability of government funding, and increasing cancer prevalence are the major drivers which are likely to anticipate the growth of epigenetics market. Increasing applications of epigenetics in personalized medicine & targeted therapy and use of epigenetics in non-oncology applications is likely to add new opportunities for this market in the coming years.
The "Global Epigenetics Market Analysis to 2025" is a specialized and in-depth study of the epigenetics industry with a focus on the global market trend. The report aims to provide an overview of global epigenetics market with detailed market segmentation by product, technology, application, end user and geography. The global epigenetics market is expected to eyewitness growth in the forecast period. The report provides key statistics on the market status of the important market players and offers key trends and opportunities in the market.
The epigenetics market is segmented based on product as reagents, kits, enzymes, instruments & consumables, and bioinformatics tools. The market by technology is categorized into histone modification, DNA methylation, and other technologies. Based on the application, the market can be segmented as metabolic diseases, oncology, cardiovascular diseases, developmental biology, and other applications. The epigenetics market based on the end-user is segmented as, academic & research institutes, contract research organizations, and pharmaceutical & biotechnology companies.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global epigenetics market based on product, technology, application, and end-user. It also provides market size and forecast till 2025 for overall in epigenetics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to dominate the epigenetics market followed by Europe. Factors such as, upsurge in epigenetics research activities, favorable government funding initiatives, great R&D expenditure, increasing occurrence of various diseases, and the presence of key players in the region can be the key factors which are likely to boost the epigenetics market in the region. However, Asia-Pacific is anticipated to possess high market potential for the growth of epigenetics market during the forecast period, owing to growing incidence of cancer and rise in healthcare expenditure. The region also expected to experience rapid market growth due to economic development.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key epigenetics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Merck KGaA, Thermo Fisher Scientific, Inc., Abcam plc, Agilent Technologies, Active Motif, Qiagen, Bio-Rad Laboratories, Inc., PerkinElmer Inc., New England Biolabs (NEB), and Illumina, Inc. among others.
Deteriorating sequencing costs & time, growing research activities, availability of government funding, and increasing cancer prevalence are the major drivers which are likely to anticipate the growth of epigenetics market. Increasing applications of epigenetics in personalized medicine & targeted therapy and use of epigenetics in non-oncology applications is likely to add new opportunities for this market in the coming years.
The "Global Epigenetics Market Analysis to 2025" is a specialized and in-depth study of the epigenetics industry with a focus on the global market trend. The report aims to provide an overview of global epigenetics market with detailed market segmentation by product, technology, application, end user and geography. The global epigenetics market is expected to eyewitness growth in the forecast period. The report provides key statistics on the market status of the important market players and offers key trends and opportunities in the market.
The epigenetics market is segmented based on product as reagents, kits, enzymes, instruments & consumables, and bioinformatics tools. The market by technology is categorized into histone modification, DNA methylation, and other technologies. Based on the application, the market can be segmented as metabolic diseases, oncology, cardiovascular diseases, developmental biology, and other applications. The epigenetics market based on the end-user is segmented as, academic & research institutes, contract research organizations, and pharmaceutical & biotechnology companies.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global epigenetics market based on product, technology, application, and end-user. It also provides market size and forecast till 2025 for overall in epigenetics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to dominate the epigenetics market followed by Europe. Factors such as, upsurge in epigenetics research activities, favorable government funding initiatives, great R&D expenditure, increasing occurrence of various diseases, and the presence of key players in the region can be the key factors which are likely to boost the epigenetics market in the region. However, Asia-Pacific is anticipated to possess high market potential for the growth of epigenetics market during the forecast period, owing to growing incidence of cancer and rise in healthcare expenditure. The region also expected to experience rapid market growth due to economic development.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key epigenetics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Merck KGaA, Thermo Fisher Scientific, Inc., Abcam plc, Agilent Technologies, Active Motif, Qiagen, Bio-Rad Laboratories, Inc., PerkinElmer Inc., New England Biolabs (NEB), and Illumina, Inc. among others.
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Epigenetics Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Epigenetics Market - By Product
3.2.2 Epigenetics Market - By Technology
3.2.3 Epigenetics Market - By Application
3.2.4 Epigenetics Market - By End User
3.2.5 Epigenetics Market - By Region
3.2.5.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis
4 Epigenetics Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Epigenetics Market Analysis- Global
5.1 Global Epigenetics Market Overview
5.2 Global Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trials
5.6 Expert Opinions
6 Epigenetics Market Revenue and Forecasts to 2025 - Product (US$ Mn)
6.1 Overview
6.2 Products Market Forecasts and Analysis
6.3 Reagents Market
6.3.1 Overview
6.3.2 Reagents Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Kits Market
6.4.1 Overview
6.4.2 Kits Market Revenue Forecasts and Analysis (US$ Mn)
6.5 Enzymes Market
6.5.1 Overview
6.5.2 Enzymes Market Revenue Forecasts and Analysis (US$ Mn)
6.6 Instruments and Consumables Market
6.6.1 Overview
6.6.2 Instruments and Consumables Market Revenue Forecasts and Analysis (US$ Mn)
6.7 Bioinformatics Tools Market
6.7.1 Overview
6.7.2 Bioinformatics Tools Market Revenue Forecasts and Analysis (US$ Mn)
7 Epigenetics Market Revenue and Forecasts to 2025 - Technology (US$ Mn)
7.1 Overview
7.2 Technology Market Forecasts and Analysis
7.3 Histone Modification Market
7.3.1 Overview
7.3.2 Histone Modification Market Revenue Forecasts and Analysis (US$ Mn)
7.4 DNA Methylation Market
7.4.1 Overview
7.4.2 DNA Methylation Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Other Technologies Market
7.5.1 Overview
7.5.2 Other Technologies Market Revenue Forecasts and Analysis (US$ Mn)
8 Epigenetics Market Revenue and Forecasts to 2025 - Application (US$ Mn)
8.1 Overview
8.2 Application Market Forecasts and Analysis
8.3 Metabolic Diseases Market
8.3.1 Overview
8.3.2 Metabolic Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Oncology Market
8.4.1 Overview
8.4.2 Oncology Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Cardiovascular Diseases Market
8.5.1 Overview
8.5.2 Cardiovascular Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.6 Developmental Biology Market
8.6.1 Overview
8.6.2 Developmental Biology Market Revenue Forecasts and Analysis (US$ Mn)
8.7 Other Applications Market
8.7.1 Overview
8.7.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
9 Epigenetics Market Revenue and Forecasts to 2025 - End User (US$ Mn)
9.1 Overview
9.2 End User Market Forecasts and Analysis
9.3 Academic & Research Institutes Market
9.3.1 Overview
9.3.2 Academic & Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
9.4 Contract Research Organizations Market
9.4.1 Overview
9.4.2 Contract Research Organizations Market Revenue Forecasts and Analysis (US$ Mn)
9.5 Pharmaceutical & Biotechnology Companies Market
9.5.1 Overview
9.5.2 Pharmaceutical & Biotechnology Companies Market Revenue Forecasts and Analysis (US$ Mn)
10 North America Epigenetics Market Revenue and Forecasts to 2025 - Country Analysis
10.1 North America Epigenetics Market Overview
10.2 North America Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
10.3 North America Market Forecasts and Analysis - By Product
10.4 North America Market Forecasts and Analysis - By Technology
10.5 North America Market Forecasts and Analysis - By Application
10.6 North America Market Forecasts and Analysis - By End User
10.7 North America Market Forecasts and Analysis - By Country
10.8 US Market Overview
10.8.1 US Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.2 US Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.8.3 US Epigenetics Market Revenue Forecasts and Analysis- By Application (US$ Mn)
10.8.4 US Epigenetics Market Revenue Forecasts and Analysis-By End User(US$ Mn)
10.9 Canada Market Overview
10.9.1 Canada Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.2 Canada Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.9.3 Canada Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9.4 Canada Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.10 Mexico Market Overview
10.10.1Mexico Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.10.2Mexico Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.10.3Mexico Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.10.4Mexico Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11 Europe Epigenetics Market Revenue and Forecasts to 2025 - Country Analysis
11.1 Europe Epigenetics Market Overview
11.2 Europe Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Europe Market Forecasts and Analysis - By Product
11.4 Europe Market Forecasts and Analysis - By Technology
11.5 Europe Market Forecasts and Analysis - By Application
11.6 Europe Market Forecasts and Analysis - By End User
11.7 Europe Market Forecasts and Analysis - By Country
11.8 UK Market Overview
11.8.1 UK Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.2 UK Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
11.8.3 UK Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8.4 UK Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.9 Germany Market Overview
11.9.1 Germany Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.2 Germany Epigenetics Market Revenue Forecasts and Analysis- By Technology (US$ Mn)
11.9.3 Germany Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9.4 Germany Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.10 France Market Overview
11.10.1France Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.10.2France Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
11.10.3France Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.10.4France Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12 Asia Pacific Epigenetics Market Revenue and Forecasts to 2025 - Country Analysis
12.1 Asia Pacific Epigenetics Market Overview
12.2 Asia Pacific Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Asia Pacific Market Forecasts and Analysis - By Product
12.4 Asia Pacific Market Forecasts and Analysis - By Technology
12.5 Asia Pacific Market Forecasts and Analysis - By Application
12.6 Asia Pacific Market Forecasts and Analysis - By End User
12.7 Asia Pacific Market Forecasts and Country- By Country
12.8 Japan Market Overview
12.8.1 Japan Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.2 Japan Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.8.3 Japan Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8.4 Japan Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.9 China Market Overview
12.9.1 China Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.2 China Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.9.3 China Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9.4 China Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.10 India Market Overview
12.10.1 India Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.10.2India Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.10.3India Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.10.4India Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13 Middle East and Africa (MEA) Epigenetics Market Revenue and Forecasts to 2025 - Geographical Analysis
13.1 Middle East & Africa (MEA) Epigenetics Market Overview
13.2 Middle East & Africa (MEA) Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East & Africa (MEA) Market Forecasts and Analysis - By Product
13.4 Middle East & Africa (MEA) Market Forecasts and Analysis - By Technology
13.5 Middle East & Africa (MEA) Market Forecasts and Analysis - By Application
13.6 Middle East & Africa (MEA) Market Forecasts and Analysis - By End User
13.7 Middle East & Africa (MEA) Market Forecasts and Analysis - By Country
13.8 South Africa Market Overview
13.8.1 South Africa Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.8.2 South Africa Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
13.8.3 South Africa Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.8.4 South Africa Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.9 Saudi Arabia Market Overview
13.9.1 Saudi Arabia Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.9.2 Saudi Arabia Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
13.9.3 Saudi Arabia Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.9.4 Saudi Arabia Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.10 UAE Market Overview
13.10.1UAE Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.10.2UAE Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
13.10.3UAE Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.10.4UAE Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
14 South and Central America Epigenetics Market Revenue and Forecasts to 2025 - Geographical Analysis
14.1 South and Central America Epigenetics Market Overview
14.2 South and Central America Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
14.3 South and Central America Market Forecasts and Analysis - By Product
14.4 South and Central America Market Forecasts and Analysis - By Technology
14.5 South and Central America Market Forecasts and Analysis - By Application
14.6 South and Central America Market Forecasts and Analysis - By End User
14.7 South and Central America Market Forecasts and Analysis - By Country
14.8 Brazil Market Overview
14.8.1 Brazil Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
14.8.2 Brazil Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
14.8.3 Brazil Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
14.8.4 Brazil Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
15 Industry Landscape
15.1 Organic Growth Strategies
15.1.1 New Product Launches
15.1.2 Marketing & Promotional Activities
15.2 Inorganic Growth Strategies
15.2.1 Partnerships, Collaborations, and Joint Ventures
15.2.2 Mergers & Acquisitions
15.2.3 Geographic Expansions
16 Epigenetics Market, Key Company Profiles
16.1 Merck KGaA
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16.1.5 Product Pipeline
16.1.6 SWOT Analysis
16.1.7 Key Developments
16.2 Thermo Fisher Scientific, Inc.
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16.2.5 Product Pipeline
16.2.6 SWOT Analysis
16.2.7 Key Developments
16.3 Abcam plc
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16.3.5 Product Pipeline
16.3.6 SWOT Analysis
16.3.7 Key Developments
16.4 Agilent Technologies
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Overview
16.4.4 Product Portfolio
16.4.5 Product Pipeline
16.4.6 SWOT Analysis
16.4.7 Key Developments
16.5 Active Motif
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Overview
16.5.4 Product Portfolio
16.5.5 Product Pipeline
16.5.6 SWOT Analysis
16.5.7 Key Developments
16.6 Qiagen
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Overview
16.6.4 Product Portfolio
16.6.5 Product Pipeline
16.6.6 SWOT Analysis
16.6.7 Key Developments
16.7 Bio-Rad Laboratories, Inc.
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16.7.5 Product Pipeline
16.7.6 SWOT Analysis
16.7.7 Key Developments
16.8 PerkinElmer Inc.
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16.8.5 Product Pipeline
16.8.6 SWOT Analysis
16.8.7 Key Developments
16.9 New England Biolabs (NEB)
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16.9.5 Product Pipeline
16.9.6 SWOT Analysis
16.9.7 Key Developments
16.10 Illumina, Inc.
16.10.1Key Facts
16.10.2Business Description
16.10.3Financial Overview
16.10.4Product Portfolio
16.10.5Product Pipeline
16.10.6SWOT Analysis
16.10.7Key Developments
17 Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
17.3 Research Methodology
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Epigenetics Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Epigenetics Market - By Product
3.2.2 Epigenetics Market - By Technology
3.2.3 Epigenetics Market - By Application
3.2.4 Epigenetics Market - By End User
3.2.5 Epigenetics Market - By Region
3.2.5.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis
4 Epigenetics Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Epigenetics Market Analysis- Global
5.1 Global Epigenetics Market Overview
5.2 Global Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trials
5.6 Expert Opinions
6 Epigenetics Market Revenue and Forecasts to 2025 - Product (US$ Mn)
6.1 Overview
6.2 Products Market Forecasts and Analysis
6.3 Reagents Market
6.3.1 Overview
6.3.2 Reagents Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Kits Market
6.4.1 Overview
6.4.2 Kits Market Revenue Forecasts and Analysis (US$ Mn)
6.5 Enzymes Market
6.5.1 Overview
6.5.2 Enzymes Market Revenue Forecasts and Analysis (US$ Mn)
6.6 Instruments and Consumables Market
6.6.1 Overview
6.6.2 Instruments and Consumables Market Revenue Forecasts and Analysis (US$ Mn)
6.7 Bioinformatics Tools Market
6.7.1 Overview
6.7.2 Bioinformatics Tools Market Revenue Forecasts and Analysis (US$ Mn)
7 Epigenetics Market Revenue and Forecasts to 2025 - Technology (US$ Mn)
7.1 Overview
7.2 Technology Market Forecasts and Analysis
7.3 Histone Modification Market
7.3.1 Overview
7.3.2 Histone Modification Market Revenue Forecasts and Analysis (US$ Mn)
7.4 DNA Methylation Market
7.4.1 Overview
7.4.2 DNA Methylation Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Other Technologies Market
7.5.1 Overview
7.5.2 Other Technologies Market Revenue Forecasts and Analysis (US$ Mn)
8 Epigenetics Market Revenue and Forecasts to 2025 - Application (US$ Mn)
8.1 Overview
8.2 Application Market Forecasts and Analysis
8.3 Metabolic Diseases Market
8.3.1 Overview
8.3.2 Metabolic Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Oncology Market
8.4.1 Overview
8.4.2 Oncology Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Cardiovascular Diseases Market
8.5.1 Overview
8.5.2 Cardiovascular Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.6 Developmental Biology Market
8.6.1 Overview
8.6.2 Developmental Biology Market Revenue Forecasts and Analysis (US$ Mn)
8.7 Other Applications Market
8.7.1 Overview
8.7.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
9 Epigenetics Market Revenue and Forecasts to 2025 - End User (US$ Mn)
9.1 Overview
9.2 End User Market Forecasts and Analysis
9.3 Academic & Research Institutes Market
9.3.1 Overview
9.3.2 Academic & Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
9.4 Contract Research Organizations Market
9.4.1 Overview
9.4.2 Contract Research Organizations Market Revenue Forecasts and Analysis (US$ Mn)
9.5 Pharmaceutical & Biotechnology Companies Market
9.5.1 Overview
9.5.2 Pharmaceutical & Biotechnology Companies Market Revenue Forecasts and Analysis (US$ Mn)
10 North America Epigenetics Market Revenue and Forecasts to 2025 - Country Analysis
10.1 North America Epigenetics Market Overview
10.2 North America Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
10.3 North America Market Forecasts and Analysis - By Product
10.4 North America Market Forecasts and Analysis - By Technology
10.5 North America Market Forecasts and Analysis - By Application
10.6 North America Market Forecasts and Analysis - By End User
10.7 North America Market Forecasts and Analysis - By Country
10.8 US Market Overview
10.8.1 US Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.2 US Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.8.3 US Epigenetics Market Revenue Forecasts and Analysis- By Application (US$ Mn)
10.8.4 US Epigenetics Market Revenue Forecasts and Analysis-By End User(US$ Mn)
10.9 Canada Market Overview
10.9.1 Canada Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.2 Canada Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.9.3 Canada Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9.4 Canada Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.10 Mexico Market Overview
10.10.1Mexico Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.10.2Mexico Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.10.3Mexico Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.10.4Mexico Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11 Europe Epigenetics Market Revenue and Forecasts to 2025 - Country Analysis
11.1 Europe Epigenetics Market Overview
11.2 Europe Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Europe Market Forecasts and Analysis - By Product
11.4 Europe Market Forecasts and Analysis - By Technology
11.5 Europe Market Forecasts and Analysis - By Application
11.6 Europe Market Forecasts and Analysis - By End User
11.7 Europe Market Forecasts and Analysis - By Country
11.8 UK Market Overview
11.8.1 UK Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.2 UK Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
11.8.3 UK Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8.4 UK Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.9 Germany Market Overview
11.9.1 Germany Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.2 Germany Epigenetics Market Revenue Forecasts and Analysis- By Technology (US$ Mn)
11.9.3 Germany Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9.4 Germany Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.10 France Market Overview
11.10.1France Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.10.2France Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
11.10.3France Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.10.4France Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12 Asia Pacific Epigenetics Market Revenue and Forecasts to 2025 - Country Analysis
12.1 Asia Pacific Epigenetics Market Overview
12.2 Asia Pacific Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Asia Pacific Market Forecasts and Analysis - By Product
12.4 Asia Pacific Market Forecasts and Analysis - By Technology
12.5 Asia Pacific Market Forecasts and Analysis - By Application
12.6 Asia Pacific Market Forecasts and Analysis - By End User
12.7 Asia Pacific Market Forecasts and Country- By Country
12.8 Japan Market Overview
12.8.1 Japan Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.2 Japan Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.8.3 Japan Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8.4 Japan Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.9 China Market Overview
12.9.1 China Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.2 China Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.9.3 China Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9.4 China Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.10 India Market Overview
12.10.1 India Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.10.2India Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.10.3India Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.10.4India Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13 Middle East and Africa (MEA) Epigenetics Market Revenue and Forecasts to 2025 - Geographical Analysis
13.1 Middle East & Africa (MEA) Epigenetics Market Overview
13.2 Middle East & Africa (MEA) Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East & Africa (MEA) Market Forecasts and Analysis - By Product
13.4 Middle East & Africa (MEA) Market Forecasts and Analysis - By Technology
13.5 Middle East & Africa (MEA) Market Forecasts and Analysis - By Application
13.6 Middle East & Africa (MEA) Market Forecasts and Analysis - By End User
13.7 Middle East & Africa (MEA) Market Forecasts and Analysis - By Country
13.8 South Africa Market Overview
13.8.1 South Africa Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.8.2 South Africa Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
13.8.3 South Africa Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.8.4 South Africa Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.9 Saudi Arabia Market Overview
13.9.1 Saudi Arabia Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.9.2 Saudi Arabia Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
13.9.3 Saudi Arabia Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.9.4 Saudi Arabia Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.10 UAE Market Overview
13.10.1UAE Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.10.2UAE Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
13.10.3UAE Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.10.4UAE Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
14 South and Central America Epigenetics Market Revenue and Forecasts to 2025 - Geographical Analysis
14.1 South and Central America Epigenetics Market Overview
14.2 South and Central America Epigenetics Market Revenue Forecasts and Analysis (US$ Mn)
14.3 South and Central America Market Forecasts and Analysis - By Product
14.4 South and Central America Market Forecasts and Analysis - By Technology
14.5 South and Central America Market Forecasts and Analysis - By Application
14.6 South and Central America Market Forecasts and Analysis - By End User
14.7 South and Central America Market Forecasts and Analysis - By Country
14.8 Brazil Market Overview
14.8.1 Brazil Epigenetics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
14.8.2 Brazil Epigenetics Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
14.8.3 Brazil Epigenetics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
14.8.4 Brazil Epigenetics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
15 Industry Landscape
15.1 Organic Growth Strategies
15.1.1 New Product Launches
15.1.2 Marketing & Promotional Activities
15.2 Inorganic Growth Strategies
15.2.1 Partnerships, Collaborations, and Joint Ventures
15.2.2 Mergers & Acquisitions
15.2.3 Geographic Expansions
16 Epigenetics Market, Key Company Profiles
16.1 Merck KGaA
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16.1.5 Product Pipeline
16.1.6 SWOT Analysis
16.1.7 Key Developments
16.2 Thermo Fisher Scientific, Inc.
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16.2.5 Product Pipeline
16.2.6 SWOT Analysis
16.2.7 Key Developments
16.3 Abcam plc
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16.3.5 Product Pipeline
16.3.6 SWOT Analysis
16.3.7 Key Developments
16.4 Agilent Technologies
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Overview
16.4.4 Product Portfolio
16.4.5 Product Pipeline
16.4.6 SWOT Analysis
16.4.7 Key Developments
16.5 Active Motif
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Overview
16.5.4 Product Portfolio
16.5.5 Product Pipeline
16.5.6 SWOT Analysis
16.5.7 Key Developments
16.6 Qiagen
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Overview
16.6.4 Product Portfolio
16.6.5 Product Pipeline
16.6.6 SWOT Analysis
16.6.7 Key Developments
16.7 Bio-Rad Laboratories, Inc.
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16.7.5 Product Pipeline
16.7.6 SWOT Analysis
16.7.7 Key Developments
16.8 PerkinElmer Inc.
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16.8.5 Product Pipeline
16.8.6 SWOT Analysis
16.8.7 Key Developments
16.9 New England Biolabs (NEB)
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16.9.5 Product Pipeline
16.9.6 SWOT Analysis
16.9.7 Key Developments
16.10 Illumina, Inc.
16.10.1Key Facts
16.10.2Business Description
16.10.3Financial Overview
16.10.4Product Portfolio
16.10.5Product Pipeline
16.10.6SWOT Analysis
16.10.7Key Developments
17 Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
17.3 Research Methodology
List of Companies
1. Merck KGaA
2. Thermo Fisher Scientific, Inc.
3. Abcam plc
4. Agilent Technologies
5. Active Motif
6. Qiagen
7. Bio-Rad Laboratories, Inc.
8. PerkinElmer Inc.
9. New England Biolabs (NEB)
10. Illumina, Inc.
1. Merck KGaA
2. Thermo Fisher Scientific, Inc.
3. Abcam plc
4. Agilent Technologies
5. Active Motif
6. Qiagen
7. Bio-Rad Laboratories, Inc.
8. PerkinElmer Inc.
9. New England Biolabs (NEB)
10. Illumina, Inc.